M&G plc’s Medical Properties Trust MPT Stock Holding History

M&G plc’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-502,862	Closed	-$2.51M	–	421
2024 Q1	$2.51M	Buy	+502,862	New	+$1.93M	0.01%	321

Other funds holding MPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

M&G plc's MPT Position: Q2 2024 in Review

M&G plc sold out of Medical Properties Trust (MPT) in Q2 2024, closing a stake of 502,862 shares — an estimated $2.51M sold.

M&G plc first reported a position in MPT in Q1 2024 and held it in 1 quarter. The position peaked at $2.51M in Q1 2024. 500 funds tracked by Wall St. Rank hold MPT as of Q2 2024.

M&G plc reported no remaining Medical Properties Trust position as of Q2 2024 after selling out during the quarter.
M&G plc sold 502,862 Medical Properties Trust shares in Q2 2024, an estimated $2.51M.
M&G plc first reported a position in Medical Properties Trust in Q1 2024 and held it in 1 quarter.
M&G plc's Medical Properties Trust position peaked at $2.51M in Q1 2024.
500 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2024.

Based on M&G plc's 13F filing for Q2 2024, filed 16 Jul 2024.